Linked Standard Research Innovation Grants

Early Career Researcher Innovation Grants (American Foundation for Suicide Prevention) is sponsored by American Foundation for Suicide Prevention (AFSP). This grant is designed to assist new researchers in obtaining advice, guidance, and supervision from an established mentor in a selected area of suicide research. The program focuses on mental health and psychology, which can encompass mood disorders.

Grants for Suicide Prevention Research (Various Programs: Pilot Innovation, Early Career Researcher Innovation, Standard Research Innovation, Distinguished Investigator Innovation, Linked Standard Research Innovation, Postdoctoral Research Fellowship Innovation, Focus Grants) is sponsored by American Foundation for Suicide Prevention (AFSP). The American Foundation for Suicide Prevention (AFSP) offers various grant programs to support studies that increase the understanding of suicide or test treatments and other interventions.

AFSP Suicide Research Grants is sponsored by American Foundation for Suicide Prevention (AFSP). The American Foundation for Suicide Prevention research grants support studies that will increase our understanding of suicide or test treatments and other interventions that save lives. Priority areas for 2024–2026 include ethnic and racial diversity in suicide prevention research.

This is a non-competitive funding opportunity intended to fund a single award. The National Institute of Neurological Disorders and Stroke is announcing its intent to issue a single source cooperative agreement award to Massachusetts General Hospital to support the renewal of the Post-Stroke Vascular Cognitive Impairment & Dementia (VCID) program, an ongoing, multi-site clinical research initiative designed to elucidate mechanisms linking stroke to subsequent cognitive impairment and dementia. The award will enable completion of the scientific aims initiated under the original U19 cooperative agreement (RFA-NS-19-012) and advance national priorities described in the National Plan to Address Alzheimer"s Disease.This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite an application from Massachusetts General Hospital. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application will be peer-reviewed, and only meritorious application(s) will be considered for funding. Funding Opportunity Number: RFA-NS-27-011. Assistance Listing: 93.853,93.866. Funding Instrument: CA. Category: HL. Award Amount: $10M total program funding.

NOTICE: Corrected July 29, 2026. Accidentally omitted standard budget requirements have been added to Table C.4-3 and Sections 3.3.3 and 3.5. New text is in bold and deleted text is struck through. The due date remains unchanged: Proposals are due November 10, 2026. NOTICE: Amended July 21, 2026. This amendment adds to ROSES-2025 this program element which was previously listed as not solicited this year. Proposals are due November 10, 2026. New this year: no Step-1 or Notice of Intent is requested. New this year: Proposals to this program element will be evaluated using a dual-anonymous peer review process. See guidelines in Section 3.13 of C.1, and in the associated "Guidelines for Anonymous Proposals" document under "Other Documents" on the NSPIRES page for this program element for the preparation of anonymous proposals. NOTICE: Research security training required starting August 5, 2026. All PIs and any Co-Is that would spend ≥ 10% time on a proposed grants or cooperative agreements must certify they have taken research security training. NASA will be satisfied with the four online research security training modules on the National Science Foundation's (NSF) Research Security Training website at https://www.nsf.gov/research-security/training or the SECURE Center condensed version of the four modules at https://www.secure-center.org/ctm NOTICE: ROSES-25 Amendment 7 makes the following changes to C.1 the Planetary Research Overview: It establishes funding threshold and submission requirements for substantial instrument or equipment requests (Section 3.11), removes the estimated page limit for pilot studies (Section 3.4) and clarifies text on use of spacecraft mission data (Section 3.5). New text is in bold and deleted text is struck through. A Planetary Science Overview FAQ has been posted under other documents on NSPIRES pages for all of Appendix C. This synopsis is a generic summary that is posted for each of the many individual "program elements" in NASA’s Research Opportunities in Space and Earth Sciences (ROSES) – 2025 solicitation. For specific information on this particular program element download and read the PDF of the text of this program element by going to Tables 2 or 3 of ROSES at https://solicitation.nasaprs.com/ROSES2025table2 and https://solicitation.nasaprs.com/ROSES2025table3, respectively, click the title of the program element of interest, a hypertext link will take you to a page for that particular program element. On that page, on the right side under "Announcement Documents" the link on the bottom will be to the PDF of the text of the call for proposals. For example, if one were interested in the Solar System Science program (NNH25ZDA001N-SCUBED) one would follow the link to the NSPIRES page for that program element and then to read the text of the call one would click on “C.2 Solar System Science (.pdf)” to download the text of the call. If one wanted to set it into the context of the goals, objectives and know the default rules for all elements within Appendix C, the planetary science division, one might download and read “C.1 Planetary Science Research Program Overview (.pdf)” from that same page. While the letters and numbers are different for each element within ROSES (A.10, B.3, etc.) the basic configuration is always the same, e.g., the letter indicates the Science Division (A is Earth Science, B is Heliophysics etc.) and whatever the letter, #1 is always the division overview. In 2025, most program elements will be set up for application via Grants.gov only if requested at least 30 days in advance of the due date. For more on Grants.gov submissions see Section IV(b)v of the ROSES Summary of Solicitation, that may be found at https://solicitation.nasaprs.com/ROSES2025. The National Aeronautics and Space Administration (NASA) Science Mission Directorate (SMD) released its annual omnibus Research Announcement (NRA), Research Opportunities in Space and Earth Sciences (ROSES) – 2025 (OMB Approval Number 2700-0092, CFDA Number 43.001) on February 21, 2025. In this case "omnibus" means that this NRA has many individual program elements, each with its own due dates and topics. All together these cover the wide range of basic and applied supporting research and technology supported by SMD. Awards will be made as grants, cooperative agreements, or contracts depending on the nature of the work proposed. However, most extramural research awards deriving from ROSES will be grants, and many program elements of ROSES specifically exclude contracts, because contracts would not be appropriate for the nature of the work solicited. Funded Co-Is at government labs will receive inter- or intra-agency transfers. The typical period of performance for an award is three years, but some programs may allow up to five years and others specify shorter periods. In most cases, organizations of every type, Government and private, for profit and not-for-profit, domestic and foreign (with some caveats), may submit proposals without restriction on teaming arrangements. Tables listing the program elements and due dates (Tables 2 and 3), a table that provides a very top level summary of proposal contents (Table 1), and the full text of the ROSES-2025 "Summary of Solicitation", may all be found NSPIRES at https://solicitation.nasaprs.com/ROSES2025. Frequently asked questions for ROSES are posted at http://science.nasa.gov/researchers/sara/faqs. Questions concerning specific program elements should be directed to the point(s) of contact for that particular element, who may be found either at the end of the individual program element in the summary table of key information or on the web list of topics and points of contact at: http://science.nasa.gov/researchers/sara/program-officers-list. General questions concerning ROSES-2025 may be directed to the office of the SMD Deputy Associate Administrator for Research at sara@nasa.gov. Not all program elements are known at the time of the release of ROSES. To be informed of new program elements or amendments to this NRA, proposers may subscribe to: (1) The SMD mailing lists (by logging in at http://nspires.nasaprs.com and checking the appropriate boxes under "Account Management" and "Email Subscriptions"), (2) The ROSES-2025 blog feed for amendments, clarifications, and corrections to at https://science.nasa.gov/researchers/solicitations/roses-2025/, and (3) The ROSES-2025 due date Google calendars (one for each science division). Instructions are at https://science.nasa.gov/researchers/sara/library-and-useful-links (link from the words due date calendar). Funding Opportunity Number: NNH25ZDA001N-PSEF. Assistance Listing: 43.001. Funding Instrument: CA,G. Category: ST.

The NIH SBIR and STTR omnibus solicitations are the largest single source of non-dilutive funding for AI and machine learning companies working in health, and the FY2026-2027 cycle refreshed them as PA-27-100 (Parent SBIR, R43/R44), PA-27-102 (Parent STTR, R41/R42), PAR-27-098 (Commercialization Readiness Pilot) and PA-27-101 (SBIR Phase IIB Strategic Breakthrough Award). Unlike a targeted RFA, the omnibus is investigator-initiated across essentially the whole NIH mission, which means an AI company can propose clinical decision support, medical imaging models, drug discovery platforms, digital diagnostics, biosignal analysis or health data infrastructure and route it to whichever institute owns the disease area. Phase I is capped at 323,090 dollars and Phase II at 2,153,927 dollars, with standard receipt dates of 5 September, 5 January and 5 April. Several FY2026 changes materially affect planning and are easy to miss. HHS now limits each small business, including affiliates, to nine SBIR/STTR submissions per fiscal year across all opportunities. Small business applications no longer qualify for the late-submission extension that other NIH applicants receive, so the deadline is absolute. And all senior and key personnel must have ORCID iDs linked to their eRA Commons profiles before submission, a registration step that takes days and blocks submission if left to the last week.